DaVita マネジメント

マネジメント基準チェック /34

DaVitaの CEO はJavier Rodriguezで、 Jun2019年に任命され、の在任期間は 5.42年です。の年間総報酬は$ 6.71Mで、 21%給与と79%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の1.02%を直接所有しており、その価値は$ 121.44M 。経営陣と取締役会の平均在任期間はそれぞれ5.1年と4.3年です。

主要情報

Javier Rodriguez

最高経営責任者

US$6.7m

報酬総額

CEO給与比率	21.0%
CEO在任期間	5.4yrs
CEOの所有権	1.0%
経営陣の平均在職期間	5.1yrs
取締役会の平均在任期間	4.3yrs

経営陣の近況

Recent updates

Is DaVita (NYSE:DVA) A Risky Investment?

Oct 29

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

Sep 16

Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Mar 13

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Mar 04

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 16

Is DaVita (NYSE:DVA) Using Too Much Debt?

Feb 08

DaVita: Assessing After The Rally

Dec 29

DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

Dec 24

DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

Nov 08

DaVita: Simple And Compelling After Sell-Off

Oct 26

Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

Oct 25

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Oct 05

Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Aug 14

DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

Jul 31

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Jul 21

Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

Jul 18

DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

Jul 03

What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?

May 01

These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively

Apr 17

Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)

Apr 03

Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?

Mar 08

DaVita HealthCare Partners Q4 2022 Earnings Preview

Feb 21

Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine

Feb 08

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Jan 24

Is DaVita (NYSE:DVA) A Risky Investment?

Jan 09

DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution

Dec 12

DaVita Q3 2022 Earnings Preview

Oct 27

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Oct 18

CEO報酬分析

DaVita の収益と比較して、Javier Rodriguez の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	US$828m
Jun 30 2024	n/a	n/a	US$860m
Mar 31 2024	n/a	n/a	US$816m
Dec 31 2023	US$7m	US$1m	US$692m
Sep 30 2023	n/a	n/a	US$596m
Jun 30 2023	n/a	n/a	US$454m
Mar 31 2023	n/a	n/a	US$500m
Dec 31 2022	US$3m	US$1m	US$547m
Sep 30 2022	n/a	n/a	US$680m
Jun 30 2022	n/a	n/a	US$834m
Mar 31 2022	n/a	n/a	US$903m
Dec 31 2021	US$3m	US$1m	US$978m
Sep 30 2021	n/a	n/a	US$984m
Jun 30 2021	n/a	n/a	US$883m
Mar 31 2021	n/a	n/a	US$791m
Dec 31 2020	US$73m	US$1m	US$783m
Sep 30 2020	n/a	n/a	US$832m
Jun 30 2020	n/a	n/a	US$824m
Mar 31 2020	n/a	n/a	US$816m
Dec 31 2019	US$17m	US$1m	US$705m
Sep 30 2019	n/a	n/a	US$623m
Jun 30 2019	n/a	n/a	US$548m
Mar 31 2019	n/a	n/a	US$551m
Dec 31 2018	US$8m	US$900k	US$616m
Sep 30 2018	n/a	n/a	US$617m
Jun 30 2018	n/a	n/a	US$698m
Mar 31 2018	n/a	n/a	US$652m
Dec 31 2017	US$8m	US$900k	US$909m

報酬と市場: Javierの総報酬 ($USD 6.71M ) は、 US市場 ($USD 12.87M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Javierの報酬は過去 1 年間で 20% 以上増加しました。

CEO（最高経営責任者

Javier Rodriguez (53 yo)

5.4yrs

在職期間

US$6,712,328

報酬

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Javier Rodriguez	CEO & Executive Director	5.4yrs	US$6.71m	1.02% $ 121.4m
Joel Ackerman	CFO & Treasurer	7.8yrs	US$6.87m	0.11% $ 13.5m
Kathleen Waters	Chief Legal & Public Affairs Officer	8.5yrs	US$5.61m	0.071% $ 8.4m
James Hearty	Chief Compliance Officer	6.7yrs	US$2.73m	0.015% $ 1.7m
David Maughan	Chief Operating Officer	less than a year	データなし	0.0073% $ 872.4k
Christopher Berry	Group VP & Chief Accounting Officer	1.3yrs	データなし	データなし
Madhu Narasimhan	Chief Information Officer	less than a year	データなし	データなし
Nic Eliason	Group Vice President of Investor Relations	no data	データなし	データなし
Jessica Hergenreter	Chief People Officer	less than a year	データなし	データなし
Misha Palecek	Chief Transformation Officer of U.S. Kidney Care Business	no data	データなし	データなし
Jeffrey Giullian	Chief Medical Officer of Kidney Care	4.8yrs	データなし	データなし
Partha Das	Chief Medical Officer of DaVita International	6.3yrs	データなし	データなし

5.1yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: DVAの経営陣は経験豊富で経験豊富です（平均在職期間は5.1年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Javier Rodriguez	CEO & Executive Director	5.4yrs	US$6.71m	1.02% $ 121.4m
Charles Berg	Director	17.7yrs	US$322.46k	0.032% $ 3.8m
Barbara Desoer	Independent Director	9.1yrs	US$384.96k	0.014% $ 1.7m
Phyllis Yale	Independent Director	8.3yrs	US$374.96k	0.019% $ 2.3m
Wendy Schoppert	Independent Director	1.3yrs	US$106.86k	0.0019% $ 219.9k
Pamela Arway	Independent Chair	15.5yrs	US$497.46k	0.030% $ 3.6m
Dennis Pullin	Independent Director	less than a year	データなし	0.00037% $ 44.0k
Adam Schechter	Independent Director	2.2yrs	US$334.96k	0.0040% $ 481.3k
Jason Hollar	Independent Director	2.5yrs	US$364.96k	0.0052% $ 613.3k
Gregory Moore	Independent Director	3.2yrs	US$355.89k	0.0066% $ 789.2k

4.3yrs

平均在職期間

61.5yo

平均年齢

経験豊富なボード: DVAの取締役会は経験豊富であると考えられます ( 4.3年の平均在任期間)。

DaVita マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

DaVita Appoints Jessica Hergenreter as Chief People Officer

CEO & Executive Director recently sold US$9.9m worth of stock

DaVita Announces Executive Appointments, Effective September 15, 2024

CEO & Executive Director recently sold US$6.3m worth of stock

Chief Legal & Public Affairs Officer recently sold US$1.1m worth of stock

Chief Legal & Public Affairs Officer notifies of intention to sell stock

Recent updates

Third quarter 2024 earnings: EPS misses analyst expectations

Is DaVita (NYSE:DVA) A Risky Investment?

DaVita Appoints Jessica Hergenreter as Chief People Officer

DaVita Inc. to Report Q3, 2024 Results on Oct 29, 2024

CEO & Executive Director recently sold US$9.9m worth of stock

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

DaVita Announces Executive Appointments, Effective September 15, 2024

DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

CEO & Executive Director recently sold US$6.3m worth of stock

New major risk - Revenue and earnings growth

Chief Legal & Public Affairs Officer recently sold US$1.1m worth of stock

Chief Legal & Public Affairs Officer notifies of intention to sell stock

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 21% overvalued

DaVita Inc. to Report Q2, 2024 Results on Aug 06, 2024

Now 20% overvalued after recent price rise

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Now 19% overvalued after recent price rise

Now 21% overvalued after recent price rise

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Now 22% overvalued after recent price rise

Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

Independent Director recently sold US$698k worth of stock

DaVita Appoints Madhu Narasimhan as Chief Information Officer, Effective June 3, 2024

Independent Director notifies of intention to sell stock

Price target increased by 9.0% to US$140

High number of new directors

DaVita Inc., Annual General Meeting, Jun 06, 2024

DaVita Inc. to Report Q1, 2024 Results on May 02, 2024

Davita Announces Dennis Pullin to Its Board of Directors

DaVita Stock Is A Hold As It Expands In Latin America

Chief Operating Officer of Kidney Care exercised options and sold US$3.0m worth of stock

Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

CEO & Executive Director exercised options and sold US$36m worth of stock

Price target increased by 7.4% to US$131

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Chief Compliance Officer recently sold US$3.0m worth of stock

Chief Compliance Officer notifies of intention to sell stock

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Price target increased by 14% to US$120

Is DaVita (NYSE:DVA) Using Too Much Debt?

DaVita Inc. to Report Q4, 2023 Results on Feb 13, 2024

DaVita: Assessing After The Rally

DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

CEO & Executive Director exercised options and sold US$16m worth of stock

Investor sentiment improves as stock rises 15%

Consensus EPS estimates increase by 13%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

DaVita: Simple And Compelling After Sell-Off

Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

DaVita Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investor sentiment deteriorates as stock falls 19%

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Chief Legal & Public Affairs Officer notifies of intention to sell stock

Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Price target increased by 7.3% to US$113

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

DaVita Inc. Announces Management Changes

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

DaVita Inc. to Report Q2, 2023 Results on Aug 03, 2023

DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

Chief Legal & Public Affairs Officer recently sold US$1.0m worth of stock

CEO & Executive Director notifies of intention to sell stock

マネジメント基準チェック /34